Watch the webinar by Prof. Fred Witjes On Thursday 21 January 2021, MML-Medical, partner of Nucleix in the Netherlands, organised the webinar “Follow-up of NMIBC, including the place of urinary markers”. The webinar included 45 minutes lecture by Prof. Dr. Fred...
Watch the presentation of Dr. Fernando Lozano Palacio (Barcelona, Spain) During the virtual VI Symposium Liquid Biopsy, organised from 25 till 27 January 2021 by a scientific committee from the University Hospital of Santiago (Spain), Dr. Fernando Lozano Palacio from...
Watch the editorial comment by Prof. Dr. Paolo Gontero on biomarker statements in the new EAU 2020 guidelines. Prof. Dr. Paolo Gontero is Professor of Urology at the University of Turin School of Medicine and Chairmen of the Division of Urology at the San Giovanni...
On Tuesday October 6th 2020, Nucleix, Israel and Palex Medical, Spain organised the webinar “Bladder EpiCheck®, for accurate, non-invasive bladder cancer monitoring”. Prof. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands,...
Watch a webinar by Prof. Fred Witjes On Thursday 24 September 2020, Nucleix, Israel and Oncotest-Rhenium, Israel organised the webinar “Follow-up of NMIBC, Including the Place of Urinary Markers”. The webinar included 45 minutes lecture by Prof. Dr. Fred Witjes,...
Reviewed by Joost Boormans (Erasmus MC Cancer Institute, Rotterdam, the Netherlands) Data from a recent study support the use of a urinary methylation-based assay, i.e. Bladder EpiCheck®, to accurately identify recurrence in patients with high-grade...
Reviewed by Morgan Rouprêt (Pitié-Salpêtrière Hospital – AP-HP Sorbonne University, Paris, France) Prof. Fred Witjes (Radboud UMC, Nijmegen, The Netherlands) recently discussed the opportunity to use urinary markers to reduce the number of cystoscopies in...
Nucleix, Israel and Oncotest-Rhenium, Israel are pleased to invite you to the webinar “Follow-up of NMIBC, Including the Place of Urinary Markers”, led by Prof. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands. The webinar...
We are excited to announce that our web platform is now available. We aim to share information on bladder cancer biomarker tests, how they can provide accurate detection of recurrence and decrease patient burden. Check out our: informative slide resource on biomarker...
This month, people around the globe are paying extra attention to bladder cancer to increase awareness. About 425,000 men and 125,000 women are diagnosed with bladder cancer each year [1]. It is the 6th most common cancer in men and is most prevalent in Europe and...
